Aaron F. Garretson

1.9k total citations
12 papers, 140 citations indexed

About

Aaron F. Garretson is a scholar working on Infectious Diseases, Epidemiology and Molecular Biology. According to data from OpenAlex, Aaron F. Garretson has authored 12 papers receiving a total of 140 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Infectious Diseases, 4 papers in Epidemiology and 2 papers in Molecular Biology. Recurrent topics in Aaron F. Garretson's work include SARS-CoV-2 and COVID-19 Research (7 papers), COVID-19 Clinical Research Studies (6 papers) and SARS-CoV-2 detection and testing (3 papers). Aaron F. Garretson is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (7 papers), COVID-19 Clinical Research Studies (6 papers) and SARS-CoV-2 detection and testing (3 papers). Aaron F. Garretson collaborates with scholars based in United States. Aaron F. Garretson's co-authors include Aaron F. Carlin, Alex E. Clark, Jialei Xie, Davey M. Smith, James R. Beadle, Tariq M. Rana, Xingquan Zhang, William Bray, Magali Porrachia and Antoine Chaillon and has published in prestigious journals such as Nature Communications, Clinical Infectious Diseases and ACS Applied Materials & Interfaces.

In The Last Decade

Aaron F. Garretson

11 papers receiving 138 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Aaron F. Garretson United States 6 87 35 32 17 15 12 140
Maxime Cochin France 6 151 1.7× 35 1.0× 41 1.3× 13 0.8× 14 0.9× 10 189
Venice Du Pont United States 6 96 1.1× 25 0.7× 44 1.4× 12 0.7× 10 0.7× 8 139
Karine Barthélémy France 4 102 1.2× 25 0.7× 33 1.0× 12 0.7× 7 0.5× 5 141
Daryl Geers Netherlands 5 93 1.1× 45 1.3× 19 0.6× 18 1.1× 6 0.4× 15 144
Fabian Pott Germany 4 70 0.8× 23 0.7× 17 0.5× 38 2.2× 26 1.7× 7 107
Adrien Delpal France 6 141 1.6× 74 2.1× 28 0.9× 21 1.2× 16 1.1× 11 216
Guillaume Lingas France 4 129 1.5× 19 0.5× 41 1.3× 11 0.6× 7 0.5× 7 157
Kathy Stephens United States 8 87 1.0× 110 3.1× 19 0.6× 18 1.1× 14 0.9× 10 209
Seble Tekle Kiros Italy 7 100 1.1× 19 0.5× 16 0.5× 15 0.9× 10 0.7× 18 123
Roy Avraham Israel 8 87 1.0× 54 1.5× 66 2.1× 60 3.5× 13 0.9× 11 209

Countries citing papers authored by Aaron F. Garretson

Since Specialization
Citations

This map shows the geographic impact of Aaron F. Garretson's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Aaron F. Garretson with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Aaron F. Garretson more than expected).

Fields of papers citing papers by Aaron F. Garretson

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Aaron F. Garretson. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Aaron F. Garretson. The network helps show where Aaron F. Garretson may publish in the future.

Co-authorship network of co-authors of Aaron F. Garretson

This figure shows the co-authorship network connecting the top 25 collaborators of Aaron F. Garretson. A scholar is included among the top collaborators of Aaron F. Garretson based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Aaron F. Garretson. Aaron F. Garretson is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

12 of 12 papers shown
1.
Wang, Ying-Ting, Jialei Xie, Fernanda Ana‐Sosa‐Batiz, et al.. (2025). Zika but not Dengue virus infection limits NF-κB activity in human monocyte-derived dendritic cells and suppresses their ability to activate T cells. Nature Communications. 16(1). 2695–2695. 3 indexed citations
2.
3.
Ray, Partha, Howard Brickner, Alex E. Clark, et al.. (2024). Design and Development of an Antigen Test for SARS-CoV-2 Nucleocapsid Protein to Validate the Viral Quality Assurance Panels. Viruses. 16(5). 662–662. 1 indexed citations
4.
Thompson, Elizabeth, Alex E. Clark, Aaron F. Garretson, et al.. (2024). Matrix-Insensitive Sensor Arrays via Peptide-Coated Nanoparticles: Rapid Saliva Screening for Pathogens in Oral and Respiratory Diseases. ACS Applied Materials & Interfaces. 16(49). 67362–67372. 2 indexed citations
5.
Carlin, Aaron F., James R. Beadle, Alex E. Clark, et al.. (2024). Oral pharmacokinetics and efficacy of oral phospholipid remdesivir nucleoside prodrugs against SARS-CoV-2 in mice. Antimicrobial Agents and Chemotherapy. 68(10). e0103924–e0103924. 1 indexed citations
6.
Retout, Maurice, et al.. (2024). Silver Nanoparticle Sensor Array for the Detection of SARS-CoV-2. ACS Applied Nano Materials. 7(8). 9136–9146. 10 indexed citations
7.
8.
Carlin, Aaron F., Alex E. Clark, Aaron F. Garretson, et al.. (2023). Neutralizing Antibody Responses After Severe Acute Respiratory Syndrome Coronavirus 2 BA.2 and BA.2.12.1 Infection Do Not Neutralize BA.4 and BA.5 and Can Be Blunted by Nirmatrelvir/Ritonavir Treatment. Open Forum Infectious Diseases. 10(4). ofad154–ofad154. 1 indexed citations
9.
Lo, Michael K., Xingquan Zhang, James R. Beadle, et al.. (2023). Enhanced broad spectrum in vitro antiviral efficacy of 3-F-4-MeO-Bn, 3-CN, and 4-CN derivatives of lipid remdesivir nucleoside monophosphate prodrugs. Antiviral Research. 219. 105718–105718. 5 indexed citations
10.
Wang, Ying-Ting, Karla M. Viramontes, Jialei Xie, et al.. (2022). SREBP2-dependent lipid gene transcription enhances the infection of human dendritic cells by Zika virus. Nature Communications. 13(1). 5341–5341. 28 indexed citations
11.
Carlin, Aaron F., Alex E. Clark, Antoine Chaillon, et al.. (2022). Virologic and Immunologic Characterization of Coronavirus Disease 2019 Recrudescence After Nirmatrelvir/Ritonavir Treatment. Clinical Infectious Diseases. 76(3). e530–e532. 34 indexed citations
12.
Schooley, Robert T., Aaron F. Carlin, James R. Beadle, et al.. (2021). Rethinking Remdesivir: Synthesis, Antiviral Activity, and Pharmacokinetics of Oral Lipid Prodrugs. Antimicrobial Agents and Chemotherapy. 65(10). e0115521–e0115521. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Maxime Cochin Breakdown of academic impact, for papers by Venice Du Pont Breakdown of academic impact, for papers by Karine Barthélémy Breakdown of academic impact, for papers by Daryl Geers Breakdown of academic impact, for papers by Fabian Pott Breakdown of academic impact, for papers by Adrien Delpal Breakdown of academic impact, for papers by Guillaume Lingas Breakdown of academic impact, for papers by Kathy Stephens Breakdown of academic impact, for papers by Seble Tekle Kiros Breakdown of academic impact, for papers by Roy Avraham
Rankless by CCL
2026